EGFR and cancer: Researchers have reported the role of miRNAs targeting key genes of the cancer pathways, such as the TP53 pathway, EGFR pathway, Mesenchymal-epithelial transition factor (c-Met) pathway, Insulin growth factor 1 receptor pathway, hypoxia and angiogenesis pathway etc., [11].